Crizanlizumab and comparators for adults with sickle cell disease: a systematic review and network meta-analysis.

Howard ThomJeroen JansenJason ShafrinLauren M ZhaoGeorge JosephHung-Yuan ChengSubhajit GuptaNirmish Shah

Published in: BMJ open (2020)

This NMA provides preliminary evidence comparing the efficacy of crizanlizumab with other treatments for VOC prevention.

Keyphrases